Clinical Trials Logo
  1. Home
  2. Rectum Cancer
  3. NCT04371198
  4. Details
NCT04371198 Clinical Trial

Patient-Derived Organoids for Rectal Cancer

Rectum Cancer Clinical Trial

Official title:
Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04371198
Other study ID # Pro00104561
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 18, 2020
Est. completion date August 17, 2022

Study information
Verified date October 2022
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.

Recruitment information / eligibility
Status Completed
Enrollment 20
Est. completion date August 17, 2022
Est. primary completion date August 17, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion 1. Age =18 years old. 2. Able to provide informed consent. 3. Undergoing proctoscopy. Exclusion 1. Patient not planned to receive neoadjuvant radiotherapy

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Biopsy
Tissue biopsy

Locations
Country Name City State
United States Duke Cancer Center Durham North Carolina

Sponsors (1)
Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of Participants With Biopsies That Form Spherical Organoids Baseline
See also
  Status Clinical Trial Phase
Suspended NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Completed NCT00409994 - Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer Phase 1/Phase 2
Active, not recruiting NCT05305820 - Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy N/A
Recruiting NCT03699761 - The Role of Pelvic Peritonization in Laparoscopic or Robotic Low Anterior Resection N/A
Recruiting NCT04907643 - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes N/A
Completed NCT03843957 - Effectiveness and Implementation of mPATH-CRC N/A
Completed NCT02423226 - Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer Phase 2
Completed NCT00509444 - Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial Phase 3
Completed NCT00379743 - Partnership for Healthy Seniors N/A
Recruiting NCT06116019 - Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Not yet recruiting NCT06066931 - Reconstruction of the Pelvic Floor and Perineal Wound After Rectal ELAPE N/A
Recruiting NCT02738359 - Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening
Completed NCT02997553 - Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery Phase 3
Active, not recruiting NCT02458664 - BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer N/A
Withdrawn NCT03257332 - Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.
Recruiting NCT05715255 - Adaptive Symptom Self-Management Immunotherapy Study N/A
Completed NCT02641691 - Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Phase 2
Recruiting NCT04405206 - Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer
Recruiting NCT03573791 - Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
Completed NCT02079389 - The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum N/A